MarketLens
Sign Up

What's Behind Trinity Biotech's Nasdaq Non-Compliance Notices

6 months ago
SHARE THIS ON:

What's Behind Trinity Biotech's Nasdaq Non-Compliance Notices

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News7 hours ago

Pathward's Credit Scare Tests Its Comeback Story

Pathward Financial's fiscal Q3 report failed to ease credit-quality concerns, following 14 months of accounting restatements and a Nasdaq listing scare. The company's comeback story faces renewed inve...
Stock News5 days ago

Biotech Is Booming, But These 2 Stocks Missed the Memo

The iShares Biotechnology ETF (IBB) rose nearly 5% Wednesday to new all-time highs, as biotech stocks enjoy one of their best stretches in years. Two unnamed stocks lagged the sector's rally.
Stock News2 weeks ago

Trinity Capital: The Selloff Made This BDC A Better Buy

Trinity Capital (TRIN) shares fell 5% after Q2 results, despite solid fundamentals. The selloff may present a better entry point if the market's negative reaction proves overdone relative to reported ...
Stock News1 months ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Trinity Biotech plans to change its ADS ratio from 1:20 to 1:600, effectively a 30-for-1 reverse ADS split, effective on or about August 5, 2026.

Breaking News

View All →

Top Headlines

View More →
Stock News54 minutes ago

Prediction: Nvidia's Shares Will Fall for a 5th Consecutive Quarter After Reporting Earnings on Aug. 26

Stock News1 hour ago

Alphabet Investors Are Still Underestimating Google Cloud

Stock News2 hours ago

Don't Sleep On Software

Stock News2 hours ago

Dickens: NVDA Now Full Stack AI Company, Blackwell & Vera Rubin Add Muscle

Stock News3 hours ago

NVIDIA, JPM & 2 More Stocks to Buy as Oil, Rates & AI Reshape Market